Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Stock Performance

STRM opened at $3.12 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. Streamline Health Solutions has a 52-week low of $1.85 and a 52-week high of $9.75. The firm has a market cap of $13.17 million, a P/E ratio of -0.63 and a beta of 1.64. The business’s fifty day moving average is $2.61 and its 200-day moving average is $5.37.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The firm had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.